Texas court awards $41m to US biotech

21-07-2022

Staff writer

Texas court awards $41m to US biotech

CrackerClips Stock Media / Shutterstock.com

Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.


Daiichi Sankyo, Seagen, cancer, oncology, patent infringement, Rodney Gilstrap, biotech, AstraZeneca

LSIPR